世界の上衣腫市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ependymoma Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2225 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、上衣腫のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（粘液乳頭型上衣腫、上衣下腫、古典的上衣腫、退形成性上衣腫）、用途別市場規模（子供、大人）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・上衣腫の市場動向 ・企業の競争状況、市場シェア ・上衣腫の種類別市場規模（粘液乳頭型上衣腫、上衣下腫、古典的上衣腫、退形成性上衣腫） ・上衣腫の用途別市場規模（子供、大人） ・上衣腫の北米市場規模2016-2027（アメリカ、カナダ） ・上衣腫のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・上衣腫のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・上衣腫の中南米市場規模2016-2027（メキシコ、ブラジル） ・上衣腫の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly、Astellas、DNAtrix、Advantagene、Burzynski Research Institute、Direct Therapeutics、Cellectar Biosciences、Amgen、Boehringer Ingelheim、Bristol-Myers Squibb、Celgene、Novartis、NewLink Genetics） ・結論

Ependymoma are tissue-based tumors arising from the cells lining the ventricles and central canal within the spinal cord.
Like many tumor types, the exact cause of ependymoma is not known. Unknown causes and lucrative revenue prospects have grabbed attention from big drug makers and thus the market is expected to exhibit significant growth in market value over the forecast years.

Market Analysis and Insights: Global Ependymoma Market
The global Ependymoma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ependymoma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ependymoma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ependymoma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ependymoma market.

Global Ependymoma Scope and Market Size
Ependymoma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ependymoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Myxopapillary Ependymomas
Subependymomas
Classic Ependymomas
Anaplastic Ependymomas

Segment by Application
Children
Adults

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly
Astellas
DNAtrix
Advantagene
Burzynski Research Institute
Direct Therapeutics
Cellectar Biosciences
Amgen
Boehringer Ingelheim
Advantagene
Burzynski Research Institute

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ependymoma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Myxopapillary Ependymomas
1.2.3 Subependymomas
1.2.4 Classic Ependymomas
1.2.5 Anaplastic Ependymomas
1.3 Market by Application
1.3.1 Global Ependymoma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Children
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ependymoma Market Perspective (2016-2027)
2.2 Ependymoma Growth Trends by Regions
2.2.1 Ependymoma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ependymoma Historic Market Share by Regions (2016-2021)
2.2.3 Ependymoma Forecasted Market Size by Regions (2022-2027)
2.3 Ependymoma Industry Dynamic
2.3.1 Ependymoma Market Trends
2.3.2 Ependymoma Market Drivers
2.3.3 Ependymoma Market Challenges
2.3.4 Ependymoma Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ependymoma Players by Revenue
3.1.1 Global Top Ependymoma Players by Revenue (2016-2021)
3.1.2 Global Ependymoma Revenue Market Share by Players (2016-2021)
3.2 Global Ependymoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ependymoma Revenue
3.4 Global Ependymoma Market Concentration Ratio
3.4.1 Global Ependymoma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ependymoma Revenue in 2020
3.5 Ependymoma Key Players Head office and Area Served
3.6 Key Players Ependymoma Product Solution and Service
3.7 Date of Enter into Ependymoma Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ependymoma Breakdown Data by Type
4.1 Global Ependymoma Historic Market Size by Type (2016-2021)
4.2 Global Ependymoma Forecasted Market Size by Type (2022-2027)

5 Ependymoma Breakdown Data by Application
5.1 Global Ependymoma Historic Market Size by Application (2016-2021)
5.2 Global Ependymoma Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ependymoma Market Size (2016-2027)
6.2 North America Ependymoma Market Size by Type
6.2.1 North America Ependymoma Market Size by Type (2016-2021)
6.2.2 North America Ependymoma Market Size by Type (2022-2027)
6.2.3 North America Ependymoma Market Size by Type (2016-2027)
6.3 North America Ependymoma Market Size by Application
6.3.1 North America Ependymoma Market Size by Application (2016-2021)
6.3.2 North America Ependymoma Market Size by Application (2022-2027)
6.3.3 North America Ependymoma Market Size by Application (2016-2027)
6.4 North America Ependymoma Market Size by Country
6.4.1 North America Ependymoma Market Size by Country (2016-2021)
6.4.2 North America Ependymoma Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Ependymoma Market Size (2016-2027)
7.2 Europe Ependymoma Market Size by Type
7.2.1 Europe Ependymoma Market Size by Type (2016-2021)
7.2.2 Europe Ependymoma Market Size by Type (2022-2027)
7.2.3 Europe Ependymoma Market Size by Type (2016-2027)
7.3 Europe Ependymoma Market Size by Application
7.3.1 Europe Ependymoma Market Size by Application (2016-2021)
7.3.2 Europe Ependymoma Market Size by Application (2022-2027)
7.3.3 Europe Ependymoma Market Size by Application (2016-2027)
7.4 Europe Ependymoma Market Size by Country
7.4.1 Europe Ependymoma Market Size by Country (2016-2021)
7.4.2 Europe Ependymoma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ependymoma Market Size (2016-2027)
8.2 Asia-Pacific Ependymoma Market Size by Type
8.2.1 Asia-Pacific Ependymoma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ependymoma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ependymoma Market Size by Type (2016-2027)
8.3 Asia-Pacific Ependymoma Market Size by Application
8.3.1 Asia-Pacific Ependymoma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ependymoma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ependymoma Market Size by Application (2016-2027)
8.4 Asia-Pacific Ependymoma Market Size by Region
8.4.1 Asia-Pacific Ependymoma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ependymoma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ependymoma Market Size (2016-2027)
9.2 Latin America Ependymoma Market Size by Type
9.2.1 Latin America Ependymoma Market Size by Type (2016-2021)
9.2.2 Latin America Ependymoma Market Size by Type (2022-2027)
9.2.3 Latin America Ependymoma Market Size by Type (2016-2027)
9.3 Latin America Ependymoma Market Size by Application
9.3.1 Latin America Ependymoma Market Size by Application (2016-2021)
9.3.2 Latin America Ependymoma Market Size by Application (2022-2027)
9.3.3 Latin America Ependymoma Market Size by Application (2016-2027)
9.4 Latin America Ependymoma Market Size by Country
9.4.1 Latin America Ependymoma Market Size by Country (2016-2021)
9.4.2 Latin America Ependymoma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ependymoma Market Size (2016-2027)
10.2 Middle East & Africa Ependymoma Market Size by Type
10.2.1 Middle East & Africa Ependymoma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ependymoma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ependymoma Market Size by Type (2016-2027)
10.3 Middle East & Africa Ependymoma Market Size by Application
10.3.1 Middle East & Africa Ependymoma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ependymoma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ependymoma Market Size by Application (2016-2027)
10.4 Middle East & Africa Ependymoma Market Size by Country
10.4.1 Middle East & Africa Ependymoma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ependymoma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Ependymoma Introduction
11.1.4 Eli Lilly Revenue in Ependymoma Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Astellas
11.2.1 Astellas Company Details
11.2.2 Astellas Business Overview
11.2.3 Astellas Ependymoma Introduction
11.2.4 Astellas Revenue in Ependymoma Business (2016-2021)
11.2.5 Astellas Recent Development
11.3 DNAtrix
11.3.1 DNAtrix Company Details
11.3.2 DNAtrix Business Overview
11.3.3 DNAtrix Ependymoma Introduction
11.3.4 DNAtrix Revenue in Ependymoma Business (2016-2021)
11.3.5 DNAtrix Recent Development
11.4 Advantagene
11.4.1 Advantagene Company Details
11.4.2 Advantagene Business Overview
11.4.3 Advantagene Ependymoma Introduction
11.4.4 Advantagene Revenue in Ependymoma Business (2016-2021)
11.4.5 Advantagene Recent Development
11.5 Burzynski Research Institute
11.5.1 Burzynski Research Institute Company Details
11.5.2 Burzynski Research Institute Business Overview
11.5.3 Burzynski Research Institute Ependymoma Introduction
11.5.4 Burzynski Research Institute Revenue in Ependymoma Business (2016-2021)
11.5.5 Burzynski Research Institute Recent Development
11.6 Direct Therapeutics
11.6.1 Direct Therapeutics Company Details
11.6.2 Direct Therapeutics Business Overview
11.6.3 Direct Therapeutics Ependymoma Introduction
11.6.4 Direct Therapeutics Revenue in Ependymoma Business (2016-2021)
11.6.5 Direct Therapeutics Recent Development
11.7 Cellectar Biosciences
11.7.1 Cellectar Biosciences Company Details
11.7.2 Cellectar Biosciences Business Overview
11.7.3 Cellectar Biosciences Ependymoma Introduction
11.7.4 Cellectar Biosciences Revenue in Ependymoma Business (2016-2021)
11.7.5 Cellectar Biosciences Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Ependymoma Introduction
11.8.4 Amgen Revenue in Ependymoma Business (2016-2021)
11.8.5 Amgen Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Ependymoma Introduction
11.9.4 Boehringer Ingelheim Revenue in Ependymoma Business (2016-2021)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Ependymoma Introduction
11.10.4 Bristol-Myers Squibb Revenue in Ependymoma Business (2016-2021)
11.10.5 Bristol-Myers Squibb Recent Development
11.11 Celgene
11.11.1 Celgene Company Details
11.11.2 Celgene Business Overview
11.11.3 Celgene Ependymoma Introduction
11.11.4 Celgene Revenue in Ependymoma Business (2016-2021)
11.11.5 Celgene Recent Development
11.12 Novartis
11.12.1 Novartis Company Details
11.12.2 Novartis Business Overview
11.12.3 Novartis Ependymoma Introduction
11.12.4 Novartis Revenue in Ependymoma Business (2016-2021)
11.12.5 Novartis Recent Development
11.13 NewLink Genetics
11.13.1 NewLink Genetics Company Details
11.13.2 NewLink Genetics Business Overview
11.13.3 NewLink Genetics Ependymoma Introduction
11.13.4 NewLink Genetics Revenue in Ependymoma Business (2016-2021)
11.13.5 NewLink Genetics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ependymoma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Myxopapillary Ependymomas
Table 3. Key Players of Subependymomas
Table 4. Key Players of Classic Ependymomas
Table 5. Key Players of Anaplastic Ependymomas
Table 6. Global Ependymoma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Ependymoma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Ependymoma Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Ependymoma Market Share by Regions (2016-2021)
Table 10. Global Ependymoma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Ependymoma Market Share by Regions (2022-2027)
Table 12. Ependymoma Market Trends
Table 13. Ependymoma Market Drivers
Table 14. Ependymoma Market Challenges
Table 15. Ependymoma Market Restraints
Table 16. Global Ependymoma Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Ependymoma Market Share by Players (2016-2021)
Table 18. Global Top Ependymoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ependymoma as of 2020)
Table 19. Ranking of Global Top Ependymoma Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Ependymoma Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Ependymoma Product Solution and Service
Table 23. Date of Enter into Ependymoma Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ependymoma Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Ependymoma Revenue Market Share by Type (2016-2021)
Table 27. Global Ependymoma Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Ependymoma Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Ependymoma Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Ependymoma Revenue Market Share by Application (2016-2021)
Table 31. Global Ependymoma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Ependymoma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Ependymoma Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Ependymoma Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Ependymoma Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Ependymoma Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Ependymoma Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Ependymoma Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Ependymoma Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Ependymoma Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Ependymoma Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Ependymoma Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Ependymoma Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Ependymoma Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Ependymoma Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Ependymoma Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ependymoma Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Ependymoma Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Ependymoma Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Ependymoma Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Ependymoma Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Ependymoma Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Ependymoma Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Ependymoma Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Ependymoma Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Ependymoma Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Ependymoma Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Ependymoma Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ependymoma Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Ependymoma Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Ependymoma Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Ependymoma Market Size by Country (2022-2027) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Ependymoma Product
Table 66. Eli Lilly Revenue in Ependymoma Business (2016-2021) & (US$ Million)
Table 67. Eli Lilly Recent Development
Table 68. Astellas Company Details
Table 69. Astellas Business Overview
Table 70. Astellas Ependymoma Product
Table 71. Astellas Revenue in Ependymoma Business (2016-2021) & (US$ Million)
Table 72. Astellas Recent Development
Table 73. DNAtrix Company Details
Table 74. DNAtrix Business Overview
Table 75. DNAtrix Ependymoma Product
Table 76. DNAtrix Revenue in Ependymoma Business (2016-2021) & (US$ Million)
Table 77. DNAtrix Recent Development
Table 78. Advantagene Company Details
Table 79. Advantagene Business Overview
Table 80. Advantagene Ependymoma Product
Table 81. Advantagene Revenue in Ependymoma Business (2016-2021) & (US$ Million)
Table 82. Advantagene Recent Development
Table 83. Burzynski Research Institute Company Details
Table 84. Burzynski Research Institute Business Overview
Table 85. Burzynski Research Institute Ependymoma Product
Table 86. Burzynski Research Institute Revenue in Ependymoma Business (2016-2021) & (US$ Million)
Table 87. Burzynski Research Institute Recent Development
Table 88. Direct Therapeutics Company Details
Table 89. Direct Therapeutics Business Overview
Table 90. Direct Therapeutics Ependymoma Product
Table 91. Direct Therapeutics Revenue in Ependymoma Business (2016-2021) & (US$ Million)
Table 92. Direct Therapeutics Recent Development
Table 93. Cellectar Biosciences Company Details
Table 94. Cellectar Biosciences Business Overview
Table 95. Cellectar Biosciences Ependymoma Product
Table 96. Cellectar Biosciences Revenue in Ependymoma Business (2016-2021) & (US$ Million)
Table 97. Cellectar Biosciences Recent Development
Table 98. Amgen Company Details
Table 99. Amgen Business Overview
Table 100. Amgen Revenue in Ependymoma Business (2016-2021) & (US$ Million)
Table 101. Amgen Recent Development
Table 102. Boehringer Ingelheim Company Details
Table 103. Boehringer Ingelheim Business Overview
Table 104. Boehringer Ingelheim Ependymoma Product
Table 105. Boehringer Ingelheim Revenue in Ependymoma Business (2016-2021) & (US$ Million)
Table 106. Boehringer Ingelheim Recent Development
Table 107. Bristol-Myers Squibb Company Details
Table 108. Bristol-Myers Squibb Business Overview
Table 109. Bristol-Myers Squibb Ependymoma Product
Table 110. Bristol-Myers Squibb Revenue in Ependymoma Business (2016-2021) & (US$ Million)
Table 111. Bristol-Myers Squibb Recent Development
Table 112. Celgene Company Details
Table 113. Celgene Business Overview
Table 114. Celgene Ependymoma Product
Table 115. Celgene Revenue in Ependymoma Business (2016-2021) & (US$ Million)
Table 116. Celgene Recent Development
Table 117. Novartis Company Details
Table 118. Novartis Business Overview
Table 119. Novartis Ependymoma Product
Table 120. Novartis Revenue in Ependymoma Business (2016-2021) & (US$ Million)
Table 121. Novartis Recent Development
Table 122. NewLink Genetics Company Details
Table 123. NewLink Genetics Business Overview
Table 124. NewLink Genetics Ependymoma Product
Table 125. NewLink Genetics Revenue in Ependymoma Business (2016-2021) & (US$ Million)
Table 126. NewLink Genetics Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ependymoma Market Share by Type: 2020 VS 2027
Figure 2. Myxopapillary Ependymomas Features
Figure 3. Subependymomas Features
Figure 4. Classic Ependymomas Features
Figure 5. Anaplastic Ependymomas Features
Figure 6. Global Ependymoma Market Share by Application: 2020 VS 2027
Figure 7. Children Case Studies
Figure 8. Adults Case Studies
Figure 9. Ependymoma Report Years Considered
Figure 10. Global Ependymoma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Ependymoma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Ependymoma Market Share by Regions: 2020 VS 2027
Figure 13. Global Ependymoma Market Share by Regions (2022-2027)
Figure 14. Global Ependymoma Market Share by Players in 2020
Figure 15. Global Top Ependymoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ependymoma as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Ependymoma Revenue in 2020
Figure 17. Global Ependymoma Revenue Market Share by Type (2016-2021)
Figure 18. Global Ependymoma Revenue Market Share by Type (2022-2027)
Figure 19. North America Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Ependymoma Market Share by Type (2016-2027)
Figure 21. North America Ependymoma Market Share by Application (2016-2027)
Figure 22. North America Ependymoma Market Share by Country (2016-2027)
Figure 23. United States Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Ependymoma Market Share by Type (2016-2027)
Figure 27. Europe Ependymoma Market Share by Application (2016-2027)
Figure 28. Europe Ependymoma Market Share by Country (2016-2027)
Figure 29. Germany Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Ependymoma Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Ependymoma Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Ependymoma Market Share by Region (2016-2027)
Figure 39. China Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Ependymoma Market Share by Type (2016-2027)
Figure 47. Latin America Ependymoma Market Share by Application (2016-2027)
Figure 48. Latin America Ependymoma Market Share by Country (2016-2027)
Figure 49. Mexico Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Ependymoma Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Ependymoma Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Ependymoma Market Share by Country (2016-2027)
Figure 55. Turkey Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Ependymoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Eli Lilly Revenue Growth Rate in Ependymoma Business (2016-2021)
Figure 59. Astellas Revenue Growth Rate in Ependymoma Business (2016-2021)
Figure 60. DNAtrix Revenue Growth Rate in Ependymoma Business (2016-2021)
Figure 61. Advantagene Revenue Growth Rate in Ependymoma Business (2016-2021)
Figure 62. Burzynski Research Institute Revenue Growth Rate in Ependymoma Business (2016-2021)
Figure 63. Direct Therapeutics Revenue Growth Rate in Ependymoma Business (2016-2021)
Figure 64. Cellectar Biosciences Revenue Growth Rate in Ependymoma Business (2016-2021)
Figure 65. Amgen Revenue Growth Rate in Ependymoma Business (2016-2021)
Figure 66. Boehringer Ingelheim Revenue Growth Rate in Ependymoma Business (2016-2021)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Ependymoma Business (2016-2021)
Figure 68. Celgene Revenue Growth Rate in Ependymoma Business (2016-2021)
Figure 69. Novartis Revenue Growth Rate in Ependymoma Business (2016-2021)
Figure 70. NewLink Genetics Revenue Growth Rate in Ependymoma Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---